Tanaz Farzan Danialifar, MD
Joel R. Rosh, MD, FAAP, FACG, AGAF
About the Broadcast and Presentation:
Once believed to be a rare disorder, congenital sucrase-isomaltase deficiency (CSID) is increasingly recognized as an overlooked cause of unexplained abdominal pain and functional GI symptoms in pediatric and adolescent patients. Characterized by reduced or absent sucrase-isomaltase enzyme activity, this genetic condition results in undigested sugars and starches in the small intestine and colon and variable symptoms that can include chronic diarrhea, abdominal pain, failure to thrive, gas, and bloating.
Join Joel Rosh, MD and Tanaz Danialifar, MD as they discuss the latest data regarding CSID and review practical strategies for recognizing and treating this condition in contemporary clinical practice.
The internet broadcast will target pediatric gastroenterologists and related health care providers.
The goal of this internet broadcast is to provide education on the latest emerging data for the management and treatment of CSID.
Upon completion of this educational activity, participants should be able to:
Accreditation Statement and Credit Designation:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of Rehoboth McKinley Christian Health Care Services (RMCHCS) and GI Health Foundation. RMCHCS is accredited by the NMMS to provide continuing medical education for physicians.
RMCHCS designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Launch date: 10/5/2020
Expiration date: 10/5/2021
To claim your CME credits, please contact the Gi Health Foundation at email@example.com to complete the evaluation form.
Supported by an educational grant from QOL Medical, LLC